Insulet’s fair value estimate has been held steady at US$377.72 per share, with only fractional tweaks to the underlying ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

PODD gains momentum as Omnipod 5 adoption accelerates, margins scale, and earnings estimates rise despite macro and concentration risks.

Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its debut at Consumer Electronics Show (CES) ...

While the 2026 J.P. Morgan Healthcare Conference has thus far failed to yield any major M&A deals for the industry, Medtronic believes the time is ripe for buyouts. | While the 2026 J.P. Morgan ...

With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...

Some of medtech's most innovative technologies were on display at the Consumer Electronics Show (CES) in Las Vegas this week.

This resulted in seven deaths and multiple injuries to various people, again, because of the inaccuracy in a specific set of ...

Baystreet.ca News Commentary – Pharmaceutical markets are witnessing drug delivery devices surge toward $862.16 billion by ...

Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat ...

Detailed price information for C.H. Robinson Ww (CHRW-Q) from The Globe and Mail including charting and trades.

Boston Scientific Corporation tops the list with its strong position in the medical device market. The company’s cardiovascular, rhythm management, and endoscopy product lines have positioned it as a ...